186 related articles for article (PubMed ID: 30825062)
1. Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.
Matsumura N; Nobusawa S; Ito J; Kakita A; Suzuki H; Fujii Y; Fukuda M; Iwasaki M; Nakasato N; Tominaga T; Natsume A; Mikami Y; Shinojima N; Yamazaki T; Nakazato Y; Hirato J; Yokoo H
J Neurooncol; 2019 May; 143(1):27-33. PubMed ID: 30825062
[TBL] [Abstract][Full Text] [Related]
2. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of a dysembryoplastic neuroepithelial tumor verified by a shared copy number gain of the tyrosine kinase domain of FGFR1.
Matsumura N; Natsume A; Maeda S; Aoki K; Yamazaki T; Nobusawa S; Yokoo H
Brain Tumor Pathol; 2020 Apr; 37(2):69-75. PubMed ID: 32297014
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
[TBL] [Abstract][Full Text] [Related]
5. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
[TBL] [Abstract][Full Text] [Related]
6. A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication.
Uchiyama T; Gomi A; Nobusawa S; Fukushima N; Matsubara D; Kawai K
Brain Tumor Pathol; 2021 Jul; 38(3):250-256. PubMed ID: 33837479
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
9. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors.
Rivera B; Gayden T; Carrot-Zhang J; Nadaf J; Boshari T; Faury D; Zeinieh M; Blanc R; Burk DL; Fahiminiya S; Bareke E; Schüller U; Monoranu CM; Sträter R; Kerl K; Niederstadt T; Kurlemann G; Ellezam B; Michalak Z; Thom M; Lockhart PJ; Leventer RJ; Ohm M; MacGregor D; Jones D; Karamchandani J; Greenwood CM; Berghuis AM; Bens S; Siebert R; Zakrzewska M; Liberski PP; Zakrzewski K; Sisodiya SM; Paulus W; Albrecht S; Hasselblatt M; Jabado N; Foulkes WD; Majewski J
Acta Neuropathol; 2016 Jun; 131(6):847-63. PubMed ID: 26920151
[TBL] [Abstract][Full Text] [Related]
10. Dysembryoplastic Neuroepithelial Tumor of the Septum Pellucidum and the Supratentorial Midline: Histopathologic, Neuroradiologic, and Molecular Features of 7 Cases.
Gessi M; Hattingen E; Dörner E; Goschzik T; Dreschmann V; Waha A; Pietsch T
Am J Surg Pathol; 2016 Jun; 40(6):806-11. PubMed ID: 26796505
[TBL] [Abstract][Full Text] [Related]
11. Genomic Analysis of Dysembryoplastic Neuroepithelial Tumor Spectrum Reveals a Diversity of Molecular Alterations Dysregulating the MAPK and PI3K/mTOR Pathways.
Surrey LF; Jain P; Zhang B; Straka J; Zhao X; Harding BN; Resnick AC; Storm PB; Buccoliero AM; Genitori L; Li MM; Waanders AJ; Santi M
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1100-1111. PubMed ID: 31617914
[TBL] [Abstract][Full Text] [Related]
12. Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas.
Trisolini E; Wardighi DE; Giry M; Bernardi P; Boldorini RL; Mokhtari K; Sanson M
J Neurooncol; 2019 Nov; 145(2):241-245. PubMed ID: 31673897
[TBL] [Abstract][Full Text] [Related]
13. Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges.
Métais A; Appay R; Pagès M; Gallardo C; Silva K; Siegfried A; Perbet R; Maurage CA; Scavarda D; Fina F; Uro-Coste E; Riffaud L; Colin C; Figarella-Branger D;
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12769. PubMed ID: 34551121
[TBL] [Abstract][Full Text] [Related]
14. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression.
Chappé C; Padovani L; Scavarda D; Forest F; Nanni-Metellus I; Loundou A; Mercurio S; Fina F; Lena G; Colin C; Figarella-Branger D
Brain Pathol; 2013 Sep; 23(5):574-83. PubMed ID: 23442159
[TBL] [Abstract][Full Text] [Related]
15. The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases.
Pagès M; Debily MA; Fina F; Jones DTW; Saffroy R; Castel D; Blauwblomme T; Métais A; Bourgeois M; Lechapt-Zalcman E; Tauziède-Espariat A; Andreiuolo F; Chrétien F; Grill J; Boddaert N; Figarella-Branger D; Beroukhim R; Varlet P
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12834. PubMed ID: 35836307
[TBL] [Abstract][Full Text] [Related]
16. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors.
Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP
Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867
[TBL] [Abstract][Full Text] [Related]
18. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.
Gessi M; Moneim YA; Hammes J; Goschzik T; Scholz M; Denkhaus D; Waha A; Pietsch T
J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.
Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C
Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415
[TBL] [Abstract][Full Text] [Related]
20. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
